AFM Portaal en AFM-website niet bereikbaar komend weekend
Vanaf vrijdag 4 oktober 21.00 uur tot zondag 6 oktober 21.00 uur is het AFM Portaal niet bereikbaar. Vanaf zaterdag 5 oktober 06.00 uur tot zondag 6 oktober 21.00 uur is de AFM-website niet bereikbaar.
OctoPlus N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
19 mei 2010 - 08:49
Statutaire naam
OctoPlus N.V.
Titel
OctoPlus publishes first quarter business update
Bericht
Highlights
Successful development of Locteron®
• Locteron Phase IIb data presented at EASL demonstrates that Locteron dosed every other week consistently achieves a reduction in flu-like side effects while maintaining antiviral efficacy comparable to the weekly dosed standard of care, providing compelling proof that Locteron offers a significant improvement in interferon therapy
• Positive Phase IIb data on Locteron further validates the clinical benefit of OctoPlus’ PolyActive® drug delivery technology
• Locteron’s Phase IIb study expected to be successfully completed in 2010
Advancing and broadening product pipeline
• Advancing our pipeline of a number of products incorporating OctoPlus’ PolyActive drug delivery technology on behalf of major biotech and pharmaceutical companies
• Expecting to significantly broaden our product pipeline in the coming year, as our drug delivery expertise has been validated by the positive results of Locteron
Q1 Financials
• Revenues coming from drug delivery programs and services (excluding Locteron) at the same level as the same period last year
• Revenues coming from Locteron in line with our expectations but substantially lower than the same period last year as development and manufacturing for phase IIb is completed
• Our expertise and knowledge from microsphere development and clinical manufacturing attracts significant interest from multiple companies, resulting in a stronger and broader acquisition pipeline of new projects than at any time in the company’s history
• Strong reduction in costs achieved compared with same period last year following the successful completion of the efficiency measures announced in September 2009
Gerelateerde downloads
Datum laatste update: 07 oktober 2024